0001814554-26-000157.txt : 20260820 0001814554-26-000157.hdr.sgml : 20260820 20260820153843 ACCESSION NUMBER: 0001814554-26-000157 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260820 DATE AS OF CHANGE: 20260820 EFFECTIVENESS DATE: 20260820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ember LifeSciences, Inc. CENTRAL INDEX KEY: 0002110315 ORGANIZATION NAME: EIN: 882571864 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-575172 FILM NUMBER: 261299687 BUSINESS ADDRESS: STREET 1: 31416 AGOURA RD STREET 2: SUITE 225 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 8053721311 MAIL ADDRESS: STREET 1: 4607 LAKEVIEW CYN RD.,#426 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 D/A 1 primary_doc.xml X0708 D/A LIVE 0002110315 Ember LifeSciences, Inc. 31416 AGOURA RD WESTLAKE VILLAGE CA CALIFORNIA 91361 805-3721311 DELAWARE None None Corporation true 2022 Timothy White 31416 Agoura Rd. Suite 225 Westlake Village CA CALIFORNIA 91361 Director Clayton Marie Alexander 31416 Agoura Rd. Suite 225 Westlake Village CA CALIFORNIA 91361 Executive Officer Director Ann Hyllengren 31416 Agoura Rd. Suite 225 Westlake Village CA CALIFORNIA 91361 Executive Officer Brian Bejarano 31416 Agoura Rd. Suite 225 Westlake Village CA CALIFORNIA 91361 Executive Officer Michael Kaufmann 31416 Agoura Rd. Suite 225 Westlake Village CA CALIFORNIA 91361 Director James DeNaut 31416 Agoura Rd. Suite 225 Westlake Village CA CALIFORNIA 91361 Director Other Technology $1 - $1,000,000 06b true 0002110315-26-000001 2025-06-16 true true false 1 50000000 32166448 17833552 $50mil in new Series A authorized alongside conversions of $55mil of prior raises SAFEs. Total amount sold includes new Series A capital only (of the $50mil authorized) that has closed as of August 20, 2026. false 50 0 0 0N/A - No finders' fees, nor commissions. 0 false Ember LifeSciences, Inc. /s/ Ann Hyllegren Ann Hyllegren Chief Financial Officer 2026-08-20